Product Code: GVR-4-68038-759-9
Botanicals And Acupuncture Market Growth & Trends:
The global botanicals and acupuncture market size is expected to reach USD 241.2 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 21.2% from 2025 to 2030. The advent of nanotechnology in acupuncture-based treatments offers lucrative growth opportunities for the market. Nanotechnology has enabled the employment of nanosensors or nanochips to offer in vivo and real-time detection solutions in reactive molecules. Assessment of connections as well as dynamics, such as reactive molecules with respect to needle stimulation, is anticipated to offer novel insights for these treatments.
The consumer base for complementary medicine has increased due to the benefits and philosophies associated with it. Some philosophies include a high preference for natural products, the onset of illness is attributed to body imbalance, the ability of the body to heal itself, the treatment of the whole body, and the administration of easier therapies. Herbal medicine, naturopathy, and homeopathy are the three most adopted complementary therapies.
Increase in the penetration of internet and e-marketing channels, such as video counseling and other electronic methods, used for patient communication boosts the botanicals segment growth. Running Pay-Per-Click (PPP) advertisements and optimization of business with a rise in the adoption of mobile phones and tablet devices are among the two effective marketing strategies for the E-distribution of botanicals.
Botanicals And Acupuncture Market Report Highlights:
- By intervention, botanicals accounted for the largest revenue share of more than 68.5% in 2024 as they are extensively used in the form of herbal supplements, homeopathic medicines, and other natural products.
- The traditional Chinese medicine therapies are finding applications in the recent treatment models associated with COVID-19 affected patients in China. This offers lucrative growth opportunities for the acupuncture market and operational entities in this market space.
- Based on distribution method, direct sales dominated the global market in 2024 as the majority of the complementary therapeutic procedures, such as naturopathy and Ayurveda, demand direct sales/distribution post medical counseling of the patient.
- The distance correspondence segment is anticipated to grow at a lucrative pace throughout the forecast period. This is due to the traction for long-distance energy treatments and virtual therapies, targeted towards increasing the salability potential of acupuncture therapies.
- Europe accounted for the largest revenue share in 2024 owing to a significant increase in the number of herbal medicine registrations, of which 600 medicines were granted with marketing authorization.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Botanicals and Acupuncture Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Billion)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Botanicals and Acupuncture Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining Power of the Suppliers
- 3.4.1.2. Bargaining Power of the Buyers
- 3.4.1.3. Threats of Substitution
- 3.4.1.4. Threats from New Entrants
- 3.4.1.5. Competitive Rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political Landscape
- 3.4.2.2. Economic and Social Landscape
- 3.4.2.3. Technological Landscape
- 3.4.2.4. Environmental Landscape
- 3.4.2.5. Legal Landscape
Chapter 4. Botanicals and Acupuncture Market: Intervention Scope Estimates & Trend Analysis
- 4.1. Intervention Scope Market Share, 2024 & 2030
- 4.2. Intervention Scope Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Intervention Scope, 2018 to 2030 (USD Billion)
- 4.4. Botanicals
- 4.4.1. Botanicals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.2. Ayurveda
- 4.4.2.1. Ayurveda Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.3. Naturopathy
- 4.4.3.1. Naturopathy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.4. Homeopathy
- 4.4.4.1. Homeopathy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.5. Acupuncture
- 4.5.1. Acupuncture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Botanicals and Acupuncture Market: Distribution Method Estimates & Trend Analysis
- 5.1. Distribution Method Market Share, 2024 & 2030
- 5.2. Distribution Method Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Method, 2018 to 2030 (USD Billion)
- 5.4. Direct Sales
- 5.4.1. Direct Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.5. E-Sales
- 5.5.1. E-Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.6. Distance Correspondence
- 5.6.1. Distance Correspondence Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Botanicals and Acupuncture Market: Regional Estimates & Trend Analysis
- 6.1. Regional Market Share Analysis, 2024 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
- 6.4. North America
- 6.4.1. North America Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.2. U.S.
- 6.4.2.1. Key Country Dynamics
- 6.4.2.2. Regulatory Framework
- 6.4.2.3. Competitive Insights
- 6.4.2.4. U.S. Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.3. Canada
- 6.4.3.1. Key Country Dynamics
- 6.4.3.2. Regulatory Framework
- 6.4.3.3. Competitive Insights
- 6.4.3.4. Canada Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4.4. Mexico
- 6.4.4.1. Key Country Dynamics
- 6.4.4.2. Regulatory Framework
- 6.4.4.3. Competitive Insights
- 6.4.4.4. Mexico Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5. Europe
- 6.5.1. Europe Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5.2. UK
- 6.5.2.1. Key Country Dynamics
- 6.5.2.2. Regulatory Framework
- 6.5.2.3. Competitive Insights
- 6.5.2.4. UK Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5.3. Germany
- 6.5.3.1. Key Country Dynamics
- 6.5.3.2. Regulatory Framework
- 6.5.3.3. Competitive Insights
- 6.5.3.4. Germany Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5.4. France
- 6.5.4.1. Key Country Dynamics
- 6.5.4.2. Regulatory Framework
- 6.5.4.3. Competitive Insights
- 6.5.4.4. France Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5.5. Italy
- 6.5.5.1. Key Country Dynamics
- 6.5.5.2. Regulatory Framework
- 6.5.5.3. Competitive Insights
- 6.5.5.4. Italy Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5.6. Spain
- 6.5.6.1. Key Country Dynamics
- 6.5.6.2. Regulatory Framework
- 6.5.6.3. Competitive Insights
- 6.5.6.4. Spain Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5.7. Denmark
- 6.5.7.1. Key Country Dynamics
- 6.5.7.2. Regulatory Framework
- 6.5.7.3. Competitive Insights
- 6.5.7.4. Denmark Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5.8. Sweden
- 6.5.8.1. Key Country Dynamics
- 6.5.8.2. Regulatory Framework
- 6.5.8.3. Competitive Insights
- 6.5.8.4. Sweden Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5.9. Norway
- 6.5.9.1. Key Country Dynamics
- 6.5.9.2. Regulatory Framework
- 6.5.9.3. Competitive Insights
- 6.5.9.4. Norway Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6. Asia Pacific
- 6.6.1. Asia Pacific Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6.2. China
- 6.6.2.1. Key Country Dynamics
- 6.6.2.2. Regulatory Framework
- 6.6.2.3. Competitive Insights
- 6.6.2.4. China Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6.3. Japan
- 6.6.3.1. Key Country Dynamics
- 6.6.3.2. Regulatory Framework
- 6.6.3.3. Competitive Insights
- 6.6.3.4. Japan Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6.4. India
- 6.6.4.1. Key Country Dynamics
- 6.6.4.2. Regulatory Framework
- 6.6.4.3. Competitive Insights
- 6.6.4.4. India Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6.5. Australia
- 6.6.5.1. Key Country Dynamics
- 6.6.5.2. Regulatory Framework
- 6.6.5.3. Competitive Insights
- 6.6.5.4. Australia Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6.6. South Korea
- 6.6.6.1. Key Country Dynamics
- 6.6.6.2. Regulatory Framework
- 6.6.6.3. Competitive Insights
- 6.6.6.4. South Korea Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6.7. Thailand
- 6.6.7.1. Key Country Dynamics
- 6.6.7.2. Regulatory Framework
- 6.6.7.3. Competitive Insights
- 6.6.7.4. Thailand Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.7. Latin America
- 6.7.1. Latin America Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.7.2. Brazil
- 6.7.2.1. Key Country Dynamics
- 6.7.2.2. Regulatory Framework
- 6.7.2.3. Competitive Insights
- 6.7.2.4. Brazil Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.7.3. Argentina
- 6.7.3.1. Key Country Dynamics
- 6.7.3.2. Regulatory Framework
- 6.7.3.3. Competitive Insights
- 6.7.3.4. Argentina Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.8. Middle East and Africa
- 6.8.1. Middle East and Africa Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.8.2. South Africa
- 6.8.2.1. Key Country Dynamics
- 6.8.2.2. Regulatory Framework
- 6.8.2.3. Competitive Insights
- 6.8.2.4. South Africa Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.8.3. Saudi Arabia
- 6.8.3.1. Key Country Dynamics
- 6.8.3.2. Regulatory Framework
- 6.8.3.3. Competitive Insights
- 6.8.3.4. Saudi Arabia Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.8.4. UAE
- 6.8.4.1. Key Country Dynamics
- 6.8.4.2. Regulatory Framework
- 6.8.4.3. Competitive Insights
- 6.8.4.4. UAE Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.8.5. Kuwait
- 6.8.5.1. Key Country Dynamics
- 6.8.5.2. Regulatory Framework
- 6.8.5.3. Competitive Insights
- 6.8.5.4. Kuwait Botanicals and Acupuncture Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Competitive Landscape
- 7.1. Participant Overview
- 7.2. Company Market Position Analysis
- 7.3. Company Categorization
- 7.4. Strategy Mapping
- 7.5. Company Profiles/Listing
- 7.5.1. Modern Acupuncture
- 7.5.1.1. Participant's Overview
- 7.5.1.2. Financial Performance
- 7.5.1.3. Product Benchmarking
- 7.5.1.4. Recent Developments/ Strategic Initiatives
- 7.5.2. ARC Acupuncture & Physical Therapy
- 7.5.2.1. Participant's Overview
- 7.5.2.2. Financial Performance
- 7.5.2.3. Product Benchmarking
- 7.5.2.4. Recent Developments/ Strategic Initiatives
- 7.5.3. Ayush Ayurveda
- 7.5.3.1. Participant's Overview
- 7.5.3.2. Financial Performance
- 7.5.3.3. Product Benchmarking
- 7.5.3.4. Recent Developments/ Strategic Initiatives
- 7.5.4. GC Biopharma Corporation
- 7.5.4.1. Participant's Overview
- 7.5.4.2. Financial Performance
- 7.5.4.3. Product Benchmarking
- 7.5.4.4. Recent Developments/ Strategic Initiatives
- 7.5.5. NatureKue, Inc.
- 7.5.5.1. Participant's Overview
- 7.5.5.2. Financial Performance
- 7.5.5.3. Product Benchmarking
- 7.5.5.4. Recent Developments/ Strategic Initiatives
- 7.5.6. Columbia Nutritional
- 7.5.6.1. Participant's Overview
- 7.5.6.2. Financial Performance
- 7.5.6.3. Product Benchmarking
- 7.5.6.4. Recent Developments/ Strategic Initiatives
- 7.5.7. Herb Pharma
- 7.5.7.1. Participant's Overview
- 7.5.7.2. Financial Performance
- 7.5.7.3. Product Benchmarking
- 7.5.7.4. Recent Developments/ Strategic Initiatives
- 7.5.8. Pure Encapsulations LLC
- 7.5.8.1. Participant's Overview
- 7.5.8.2. Financial Performance
- 7.5.8.3. Product Benchmarking
- 7.5.8.4. Recent Developments/ Strategic Initiatives
- 7.5.9. Sheng Chang Pharmaceutical Company
- 7.5.9.1. Participant's Overview
- 7.5.9.2. Financial Performance
- 7.5.9.3. Product Benchmarking
- 7.5.9.4. Recent Developments/ Strategic Initiatives
- 7.5.10. LKK Health Products Group Limited
- 7.5.10.1. Participant's Overview
- 7.5.10.2. Financial Performance
- 7.5.10.3. Product Benchmarking
- 7.5.10.4. Recent Developments/ Strategic Initiatives
- 7.5.11. Nordic Neutraceuticals
- 7.5.11.1. Participant's Overview
- 7.5.11.2. Financial Performance
- 7.5.11.3. Product Benchmarking
- 7.5.11.4. Recent Developments/ Strategic Initiatives
- 7.5.12. Helio USA, Inc.
- 7.5.12.1. Participant's Overview
- 7.5.12.2. Financial Performance
- 7.5.12.3. Product Benchmarking
- 7.5.12.4. Recent Developments/ Strategic Initiatives